Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression
By Lori Solomon HealthDay Reporter
MONDAY, Dec. 23, 2024 -- A high omega-3, low omega-6 diet with fish oil supplementation for one year results in a significant reduction of a marker of prostate cancer progression among men enrolled in active surveillance (AS), according to a study published online Dec. 13 in the Journal of Clinical Oncology.
William J. Aronson, M.D., from the University of California, Los Angeles, and colleagues examined whether a high omega-3, low omega-6 fatty acid diet with fish oil capsules (D + FO) decreases proliferation (Ki-67) in prostate biopsies in men with prostate cancer over one year of AS. The analysis included 100 men with grade 1 or 2 prostate cancer who elected AS.
The researchers found that the Ki-67 index decreased in the D + FO group by approximately 15 percent from baseline to one year (1.34 to 1.14 percent at one year) and increased in the control group by approximately 24 percent from baseline to one year (1.23 to 1.52 percent at one year), yielding a statistically significant difference in the change of the Ki-67 index between the groups. For the secondary outcomes, grade group, tumor length, Decipher genomic score, and prostate-specific antigen did not significantly differ between the two groups. In the D + FO group, four patients withdrew from the trial because of adverse events related to the FO.
"These findings support future phase III trials incorporating this intervention in men on AS," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Acupuncture May Alleviate Nocturia in Men Treated for Prostate Cancer
TUESDAY, June 3, 2025 -- Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online May 29 in JAMA...
Stereotactic Body Radiotherapy Feasible After Radical Prostatectomy
TUESDAY, May 20, 2025 -- Post-radical prostatectomy (post-RP) stereotactic body radiotherapy (SBRT) is well tolerated, with patient-reported outcomes (PROs) comparable to those...
MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer
MONDAY, May 19, 2025 -- Use of magnetic resonance imaging (MRI)-guided biopsy (MRGB) could increase the durability of active surveillance (AS) in men with prostate cancer...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.